m*z
发帖数: 2356 | 1 about to break out again. | w***y
发帖数: 2537 | 2 nice call
did not follow :( | L********3
发帖数: 2272 | | m*z
发帖数: 2356 | 4 这是我最近第二次PUMP. 一月也PUMP过一次.
【在 L********3 的大作中提到】
: 这个很猛，俺去追点如何呢?
| m*z
发帖数: 2356 | | u*****n
发帖数: 778 | | m*z
发帖数: 2356 | 7 Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged
in the discovery and development of drugs for the treatment of human viral
diseases with operations in the United States and Europe. The Company抯
research and development focus is on the treatment of hepatitis C virus (HCV
). In July 2009, the Company completed the proof-of-concept clinical trial
in treatment-naive HCV genotype I infected patients. In October 2009, it
initiated a 14-day dose-ranging phase IIa clinical trial evaluating IDX184
in combination with pegylated interferon and ribavirin in treatment-naive
HCV genotype I infected patients. Idenix selected IDX320 as its lead
clinical candidate from its protease inhibitor discovery program. The
Company has also developed products and drug candidates for the treatment of
hepatitis B virus (HBV), human immunodeficiency virus type I (HIV) and
acquired immune deficiency syndrome (AIDS).
【在 u*****n 的大作中提到】
: 能给讲讲公司是干什么的么？
| h*****8
发帖数: 4754 | 8 看着不错，关注下往哪走.
【在 m*z 的大作中提到】
: 再次创新高, 可能会继续沿着BB的上沿走.
|
|
